Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Brain Pathol. 2008 Oct 21;19(3):449–458. doi: 10.1111/j.1750-3639.2008.00225.x

Figure 3. Western blot analysis with a BRAF antibody demonstrated variable protein expression in tumors with and without the 7q34 duplication.

Figure 3

Fifty micrograms of tumor lysate was probed with anti-BRAF (A), anti-ACTIVE MAPK (B) and anti-total MAPK (C). Lanes (4) 06–219, (5) 01–080, (6) 99–146, and (8) 04–098 were from tumors with the 7q34 duplication. Lanes 1 (00–309), 3 (05–040) and 7 (05–255) were from tumors without the duplication. Lane 2 (01–122) was the only tumor with a V600E BRAF mutation.